CLRB - Interest in Cellectar increases with private equity purchases

Interest in Cellectar Biosciences (CLRB) from private equity firms this week jumped this week as evidenced by several SEC Form 13G and Form 13G/A amended filings.This week, Consonance Capital Management and Sio Capital Management both filed Form 13G.Consonance's filing lists 4,703,435 shares representing 9.99% of all common shares.Sio's filing lists 2,331,123 shares representing 8.69% of all common shares.Boxer Capital filed a 13G/A listing 1.84M shares representing 4% of common shares.North Sound Management filed a 13G/A listing 2,164,950 shares representing 4.8% of common shares.Cellectar shares are up 0.4% to $2.47 in morning trading.

For further details see:

Interest in Cellectar increases with private equity purchases